| scholarly article | Q13442814 |
| P2093 | author name string | Antonio Salvetti | |
| Adamasco Cupisti | |||
| Giuliano Barsotti | |||
| Stefano Taddei | |||
| Lorenzo Ghiadoni | |||
| Heloise Cardinal | |||
| Paola Mattei | |||
| Stefania Favilla | |||
| Paolo Rindi | |||
| Yale Huang | |||
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 512-519 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Journal of Nephrology | Q15765408 |
| P1476 | title | Endothelial dysfunction and oxidative stress in chronic renal failure | |
| P478 | volume | 17 |
| Q37393223 | Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis |
| Q88410127 | Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials |
| Q40041537 | Angiotensin II Blockade and Total Cardiovascular Risk : Beyond Blood Pressure Reduction |
| Q61817225 | Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence? |
| Q34008329 | Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease |
| Q64245767 | Assessment of subclinical atherosclerosis and endothelial dysfunction in chronic kidney disease by measurement of carotid intima media thickness and flow-mediated vasodilatation in North Indian population |
| Q90721116 | Association between Serum Indoxyl Sulfate Levels and Endothelial Function in Non-Dialysis Chronic Kidney Disease |
| Q35127719 | Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension |
| Q89833656 | Asymmetric Dimethylarginine does not Predict Early Access Events in Hemodialysis Patients with Brachiocephalic Fistula Access |
| Q33582866 | Circulating endothelial progenitor cells: a new approach to anti-aging medicine? |
| Q51730619 | Dietary intake of inorganic phosphorus has a stronger influence on vascular-endothelium function than organic phosphorus. |
| Q33342286 | Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure |
| Q36126483 | Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus |
| Q36560954 | Effect of vitamin C on endothelial function of children with chronic renal failure: An experimental study |
| Q54983740 | Endothelial Dysfunction in Kidney Transplantation. |
| Q33610670 | Endothelial dysfunction as a target for prevention of cardiovascular disease |
| Q34747124 | Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation |
| Q40091727 | Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease |
| Q38195264 | Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. |
| Q34130840 | FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. |
| Q48040831 | IL-1 Inhibition and Vascular Function in CKD. |
| Q43268228 | Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease |
| Q90671729 | Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders |
| Q36076844 | Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults |
| Q33764561 | NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease |
| Q83203740 | Nocturnal hemodialysis |
| Q90434493 | Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD |
| Q43375953 | Oxidative Stress in Hemodialysis Patients: A Review of the Literature. |
| Q35012914 | Peripheral vascular dysfunction in chronic kidney disease |
| Q34591350 | Prospects for renovascular protection by more aggressive renin-angiotensin system control. |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q36475601 | Reduced Residual Renal Function is Associated with Endothelial Dysfunction in Patients Receiving Peritoneal Dialysis |
| Q37150714 | Relations of measures of endothelial function and kidney disease: the Framingham Heart Study |
| Q34498076 | Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease |
| Q46265555 | THE ROLE OF MITOCHONDRIA DERIVED REACTIVE OXYGEN SPECIES IN MICROVASCULAR DYSFUNCTION IN CHRONIC KIDNEY DISEASE. |
| Q38836199 | Targeting vascular (endothelial) dysfunction. |
| Q38886600 | The increasing financial impact of chronic kidney disease in australia. |
| Q47208232 | Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2. |
| Q37259842 | Urinary leukotriene E4 is associated with renal function but not with endothelial function in type 2 diabetes. |
| Q55077663 | Vascular Function and Uric Acid-Lowering in Stage 3 CKD. |
| Q39085572 | Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study |
| Q36691351 | Vitamin E in renal therapeutic regiments |
| Q46441398 | Xanthine oxidase and the beneficial effect of allopurinol on blood pressure and renal function |
| Q34724151 | p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation/atherosclerosis-related modulators production in endothelial cells and mononuclear cells. |
Search more.